Mohamed Shaker

1.0k total citations
46 papers, 704 citations indexed

About

Mohamed Shaker is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Mohamed Shaker has authored 46 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hepatology, 29 papers in Epidemiology and 14 papers in Surgery. Recurrent topics in Mohamed Shaker's work include Liver Disease Diagnosis and Treatment (24 papers), Hepatocellular Carcinoma Treatment and Prognosis (14 papers) and Liver Disease and Transplantation (12 papers). Mohamed Shaker is often cited by papers focused on Liver Disease Diagnosis and Treatment (24 papers), Hepatocellular Carcinoma Treatment and Prognosis (14 papers) and Liver Disease and Transplantation (12 papers). Mohamed Shaker collaborates with scholars based in Egypt, United States and Philippines. Mohamed Shaker's co-authors include Imam Waked, Manal H. El‐Sayed, Magdy El‐Serafy, Gamal Esmat, Wahid Doss, Mohamed Hassany, Wafaa Elakel, Kadry Elsaeed, David M. Fleischer and Edmond S. Chan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Allergy and Clinical Immunology and Journal of Hepatology.

In The Last Decade

Mohamed Shaker

44 papers receiving 689 citations

Peers

Mohamed Shaker
Justin Parekh United States
Imen Sfar Tunisia
Malte Heeg Germany
Francesca Saffioti United Kingdom
WJ Tremaine United States
Mohamed Shaker
Citations per year, relative to Mohamed Shaker Mohamed Shaker (= 1×) peers J.‐P. Bronowicki

Countries citing papers authored by Mohamed Shaker

Since Specialization
Citations

This map shows the geographic impact of Mohamed Shaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed Shaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed Shaker more than expected).

Fields of papers citing papers by Mohamed Shaker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed Shaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed Shaker. The network helps show where Mohamed Shaker may publish in the future.

Co-authorship network of co-authors of Mohamed Shaker

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed Shaker. A scholar is included among the top collaborators of Mohamed Shaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed Shaker. Mohamed Shaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mostafa, Aya, Ossama Ashraf Ahmed, Hany Dabbous, et al.. (2021). The outcome of re-treatment of relapsed hepatitis C virus infection in a resource-limited setting. VirusDisease. 32(3). 582–588. 1 indexed citations
3.
Shaker, Mohamed, et al.. (2018). Validation of AFP Model as a Predictor of Response, Recurrence and Survival in HCC Patients Underwent Locoregional Treatment. The Egyptian Journal of Hospital Medicine. 72(10). 5470–5478. 1 indexed citations
4.
Shaker, Mohamed, et al.. (2018). Outcome of transarterial chemoembolization in Egyptian patients with hepatocellular carcinoma and branch portal vein thrombosis. Indian Journal of Gastroenterology. 37(2). 127–132. 2 indexed citations
5.
Shaker, Mohamed, et al.. (2018). Efficacy of loco-regional treatment for hepatocellular carcinoma prior to living donor liver transplantation: a report from a single center in Egypt. Journal of Hepatocellular Carcinoma. Volume 5. 29–36. 6 indexed citations
6.
Azim, Hamdy A., Ashraf Omar, Mohamed Shaker, et al.. (2018). Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study). Journal of Hepatocellular Carcinoma. Volume 5. 109–119. 19 indexed citations
7.
Shaker, Mohamed, et al.. (2018). Outcome of Transjugular Intrahepatic Portosystemic Shunt in Budd-Chiari Syndrome: Long-Term Outcomes of 118 Patients; A Single-center Experience. SHILAP Revista de lepidopterología. 2(2). 75–81. 1 indexed citations
8.
Shaker, Mohamed, et al.. (2017). Endoscopic inlay butterfly cartilage Myringoplasty for central perforation. International Journal of Multidisciplinary Research and Development. 4(1). 107–110.
9.
Elsharkawy, Aisha, Maissa El Raziky, Wafaa Elakel, et al.. (2017). Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: Lessons from the Egyptian experience. Journal of Hepatology. 68(4). 691–698. 50 indexed citations
10.
Shaker, Mohamed, et al.. (2017). Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients. World Journal of Hepatology. 9(9). 469–469. 25 indexed citations
11.
Sakr, Mohamed, et al.. (2016). Characteristics of hepatocellular carcinoma in Egyptian patients with primary Budd‐Chiari syndrome. Liver International. 37(3). 415–422. 12 indexed citations
12.
Shaker, Mohamed, et al.. (2015). Extrahepatic metastases as initial manifestations of hepatocellular carcinoma: an Egyptian experience. Diagnostic Pathology. 10(1). 82–82. 13 indexed citations
13.
Dabbous, Hany, et al.. (2013). Feasibility of Anticoagulation in Patients of Budd-chiari Syndrome with Gastroesophageal Varices and Portal Hypertension. Journal of Gastroenterology and Hepatology Research. 2(5). 581–584. 5 indexed citations
14.
Abdel‐Rahman, Omar, et al.. (2013). Sorafenib for Egyptian patients with advanced hepatocellular carcinoma; single center experience. Journal of the Egyptian National Cancer Institute. 26(1). 9–13. 18 indexed citations
16.
Ismail, Alaa, et al.. (2010). Simultaneous Injection of Autologous Mononuclear Cells with TACE in HCC Patients; Preliminary Study. Journal of Gastrointestinal Cancer. 42(1). 11–19. 5 indexed citations
17.
El‐Meteini, Mahmoud, Alaa F. Hamza, Mohamed Fathy, et al.. (2010). Biliary complications including single-donor mortality: experience of 207 adult-to-adult living donor liver transplantations with right liver grafts. HPB. 12(2). 109–114. 30 indexed citations
18.
Shaker, Mohamed, et al.. (1997). Immunological disorders in chronic hepatitis C Egyptian patients.. PubMed. 72(1-2). 53–65. 1 indexed citations
19.
Darwish, Medhat A., et al.. (1992). Delta virus infection in Egypt.. PubMed. 67(1-2). 147–61. 11 indexed citations
20.
Shaker, Mohamed, et al.. (1992). Non-A, non-B viral hepatitis in Egypt.. PubMed. 67(1-2). 171–9. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026